Reunion Neuroscience establishes $10M at-the-market equity facility

• Reunion Neuroscience (NASDAQ:REUN) has entered into an equity distribution pact with Canaccord Genuity to establish an at-the-market equity facility.
• Pursuant to the at-the-market equity facility, the company may, at its discretion sell up to $10M of its common shares through "at-the-market" issuances on the Nasdaq Stock Market in the United States.
• No common shares will be offered or sold on the Toronto Stock Exchange or any other marketplace in Canada.
• Net proceeds from the ATM Facility will be used for general corporate purposes to fund ongoing operations.